Aetna to sell its Medicare Part D drug plan

In the hopes of winning regulatory approval from the Trump administration, Aetna has agreed to sell its Medicare Part D drug plan business to the WellCare Health Plans. As of June 30, Aetna said in a filing with the Securities and Exchange Commission, the business being sold had about 2.2 million members. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.